Feb 12, 2020 / 12:00AM GMT
Presentation
Feb 12, 2020 / 12:00AM GMT
=====================
Corporate Participants
=====================
* David Mark Lamont
CSL Limited - CFO
* Mark Dehring
CSL Limited - Head of IR
* Paul R. Perreault
CSL Limited - MD, CEO & Executive Director
=====================
Conference Call Participants
=====================
* Andrew Goodsall
MST Marquee - Healthcare analyst
* Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst
* David A. Low
JP Morgan Chase & Co, Research Division - Research Analyst
* David Andrew Stanton
Jefferies LLC, Research Division - Equity Analyst
* David Bailey
Macquarie Research - Research Analyst
* Gretel Janu
Crédit Suisse AG, Research Division - Research Analyst
* John Deakin-Bell
Citigroup Inc, Research Division - Director & Head of Healthcare in Australia and New Zealand
* Lyanne Harrison
BofA Merrill Lynch, Research Division - VP
* Saul
CSL Ltd
(HAM:CSJ)
€
68.23
+0.050 (+0.07%)
Market Cap: 32.84 Bil
Enterprise Value: 43.24 Bil
PE Ratio: 94.26
PB Ratio: 2.00
GF Score: 73/100 Half Year 2020 CSL Ltd Earnings Presentation Transcript
Feb 12, 2020 / 12:00AM GMT
Release Date Price:
€204
(+2.62%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot